Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 19/20 | 1.00 |
| ▸ | LCK | P06239 | 17/20 | 1.00 |
| ▸ | TEK | Q02763 | 16/20 | 1.00 |
| ▸ | KDR | P35968 | 8/20 | 0.65 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.64 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.64 |
| ▸ | FYN | P06241 | 2/20 | 0.61 |
| ▸ | BTK | Q06187 | 1/20 | 0.56 |
| ▸ | EGFR | P00533 | 4/20 | 0.54 |
| ▸ | ABL1 | P00519 | 3/20 | 0.54 |
| ▸ | HCK | P08631 | 3/20 | 0.54 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.54 |
| ▸ | ERBB4 | Q15303 | 2/20 | 0.54 |
| ▸ | PLK4 | O00444 | 1/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.54 |
| ▸ | PAK4 | O96013 | 1/20 | 0.54 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.54 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.54 |
| ▸ | INSR | P06213 | 1/20 | 0.54 |
| ▸ | CSF1R | P07333 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7702761 | 1.00 | SRC (1.00) | SRCLCKTEKKDRLIMK1 | |
| Acetic Acid SCHEMBL6430304 | 0.96 | LCK (0.92) | SRCLCKTEKKDRLIMK1 | |
| Acetic Acid SCHEMBL6430306 | 0.96 | LCK (0.92) | SRCLCKTEKKDRLIMK1 | |
| SCHEMBL5815010 | 0.96 | LCK (0.92) | SRCLCKTEKKDRLIMK1 | |
| SCHEMBL6431132 | 0.88 | LCK (0.79) | SRCLCKTEKKDRLIMK1 | |
| SCHEMBL6883643 | 0.88 | LCK (0.79) | SRCLCKTEKKDRLIMK1 | |
| SCHEMBL6883639 | 0.88 | LCK (0.79) | SRCLCKTEKKDRLIMK1 | |
| SCHEMBL6431127 | 0.88 | LCK (0.79) | SRCLCKTEKKDRLIMK1 | |
| SCHEMBL6431352 | 0.88 | SRC (1.00) | SRCLCKTEKKDRLIMK1 | |
| SCHEMBL6430666 | 0.88 | SRC (0.83) | SRCLCKTEKKDRLIMK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020156081-A1 | Pyrazolopyrimidines as therapeutic agents | ABBOTT LABORATORIES (US) | 2002-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156081-A1 | Pyrazolopyrimidines as therapeutic agents | DPYD, CYP2D6, UGT1A1 | SRC 1834/4885LCK 1011/4885TEK 1657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.